Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapine.

Clozapine Double-Blind Method Hallucinations / therapy Humans Schizophrenia / drug therapy Schizophrenic Psychology Transcranial Magnetic Stimulation Treatment Outcome
Schizophrenia clozapine meta-analysis rTMS response

Journal

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
ISSN: 1814-1412
Titre abrégé: World J Biol Psychiatry
Pays: England
ID NLM: 101120023

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 23 2 2020
medline: 29 6 2021
entrez: 22 2 2020
Statut: ppublish

Résumé

Biological strategies to improve treatment efficacy in clozapine-treated patients are urgently needed. Repetitive transcranial magnetic stimulation (rTMS) merits consideration as intervention for patients with persistent auditory hallucinations (AH) or negative symptoms (NS) not responding sufficiently to clozapine treatment. Data from 10 international RCTs of rTMS for patients being treated with clozapine were pooled. Two levels of symptomatic response were defined: improvement of Analyses of 131 patients did not reveal a significant difference for rTMS as a treatment for persistent symptoms in clozapine-treated patients did not show a beneficial effect of active compared to sham treatment. For AH, the size of the NNTs indicates a possible beneficial effect of rTMS.

Identifiants

DOI: 10.1080/15622975.2020.1733080 PMID: 32081071
pubmed: 32081071
doi: 10.1080/15622975.2020.1733080
doi:

Substances chimiques

Clozapine J60AR2IKIC

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

14-26

Auteurs

Elias Wagner (E)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

William G Honer (WG)

Department of Psychiatry, The University of British Columbia, Vancouver, Canada.

Iris E Sommer (IE)

Department of Biomedical Sciences of Cells and Systems, Section Cognitive Neuropsychology, University Medical Center Groningen, Groningen, the Netherlands.

Sanne Koops (S)

Department of Psychiatry, University Medical Center Utrecht, Utrecht, the Netherlands.

Daniel M Blumberger (DM)

Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Canada.
Campbell Family Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
Department of Psychiatry, University of Toronto, Toronto, Canada.

Zafiris J Daskalakis (ZJ)

Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Canada.
Campbell Family Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
Department of Psychiatry, University of Toronto, Toronto, Canada.

Jozarni J Dlabac-De Lange (JJ)

Lentis Psychiatric Institute, Groningen, the Netherlands.
University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Leonie Bais (L)

Lentis Psychiatric Institute, Groningen, the Netherlands.

Henderikus Knegtering (H)

Lentis Psychiatric Institute, Groningen, the Netherlands.
University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

André Aleman (A)

Lentis Psychiatric Institute, Groningen, the Netherlands.
University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Tomas Novak (T)

Klecany and Third Faculty of Medicine, Charles University, National Institute of Mental Health, Prague, Czech Republic.

Monika Klirova (M)

Klecany and Third Faculty of Medicine, Charles University, National Institute of Mental Health, Prague, Czech Republic.

Christina Slotema (C)

Department of Personality Disorders, Parnassia Psychiatric Institute, the Hague, Netherlands.

Jerome Brunelin (J)

INSERM U1028, CNRS UMR 5292, CRNL, Centre Hospitalier Le Vinatier, Bron, France.

Emmanuel Poulet (E)

INSERM U1028, CNRS UMR 5292, CRNL, Centre Hospitalier Le Vinatier, Bron, France.

Milenko Kujovic (M)

Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University Hospital, Düsseldorf, Germany.

Joachim Cordes (J)

Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University Hospital, Düsseldorf, Germany.

Thomas Wobrock (T)

Department of Psychiatry and Psychotherapy, Georg-August-University, Goettingen, Germany.
Centre of Mental Health, County Hospitals Darmstadt-Dieburg, Groß-Umstadt, Germany.

Dan Siskind (D)

School of Medicine, University of Queensland, Brisbane, Australia.
Metro South Addiction and Mental Health Service, Brisbane, Australia.

Peter Falkai (P)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Thomas Schneider-Axmann (T)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Alkomiet Hasan (A)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérocycliques 3 noyaux › Dibenzazépines › Clozapine › Repetitive transcranial magnetic stimulation...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Méthode en double aveugle › Repetitive transcranial magnetic stimulation...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Manifestations neurocomportementales › Troubles de la perception › Hallucinations › Repetitive transcranial magnetic stimulation...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Repetitive transcranial magnetic stimulation...
questionsmedicales.fr › Troubles mentaux › Schizophrénie et troubles avec traits psychotiques › Schizophrénie › Repetitive transcranial magnetic stimulation...
questionsmedicales.fr › Disciplines et activités comportementales › Psychologie des schizophrènes › Repetitive transcranial magnetic stimulation...
questionsmedicales.fr › Thérapeutique › Magnétothérapie › Stimulation magnétique transcrânienne › Repetitive transcranial magnetic stimulation...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Repetitive transcranial magnetic stimulation...